Clearmind Medicine Inc. (CMND) NASDAQ

2.59

-0.15(-5.47%)

Updated at December 22 04:00PM

Currency In USD

Valuation

Market Cap172.36M
Enterprise Value165.84M
P/E Ratio-3.41
PEG Ratio-0.12
Price/Sales Ratio0
Price/Book Ratio12.98
Enterprise/Revenue0
Enterprise/EBITDA0.65

Fiscal Year

Fiscal YearOctober 31, 2024
Most Recent QuarterJuly 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.02
Return On Equity-1.74

Income Statement

Revenue0
Revenue/Share0
Gross Profit-26,703
EBITDA-7.98M
Net Income-5.25M
Diluted EPS-2.36

Balance Sheet

Total Cash3.5M
Total Cash/Share0.65
Total Debt28,439
Total Debt/Equity0.03
Current Ratio1.32
Book Value Per Share0.2

Price History

52-Week Change-94.69
52-Week High87.2
52-Week Low2.36
Moving Average 50 Days19.67
Moving Average 200 Days35.03

Statistics

Average Volume371,797
Shares Outstanding136,659
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:40
Last Split DateDecember 15, 2025